Site map

Media

News & press releases

Events

Scientific publications

Posters

2010

ISMRM 2010 #975

In vivo characterisation of orthotopic prostate tumor and healthy rat prostate metabolism using ¹H-MRS at 4.7 T

X. Tizon^a, P. Provent^a, S. Parfait^{b, c}, G. Créhange^d, J. Mitéran^{b, c}, P. Genne^a, F. Brunotte^{b, c, d}, O. Duchamp^a and P. Walker^{b, c}
^aOncodesign, ^bLE2I, ^cCNRS UMR 5158, ^dCGFL

Download

AACR 2010 #740

Oncodesign translational drug discovery process

J.F. Mirjolet^a, F. Bichat^a, X. Tizon^a, G. Serin^a, Z. Koob^a, O. Duchamp^a, P. Blom^a, C. Berthet^a, P. Genne^a and J. Hoflack^a
^aOncodesign

Download

AACR 2010 #394

Development of a fully human immune system in NOD/SCID/ IL2Rgamma (NSG) mice for oncology research purpose

J.F. Mirjolet^a, M. Hillairet de Boisferon^a, F. Bichat^a, C. Fages^b and R. Matyas^b
^aOncodesign, ^bsanofi-aventis

Download

AACR 2010 #571

PK and antitumor activity of DEBIO 0507, a new platine derivative, in preclinical tumor models

C. Mignard^a, V. Bari^a, F. Bichat^a, L. Cicurel^b, G. Vuagniaux^b and M. Barbier^b
^aOncodesign, ^bDebiopharm

Download

AACR 2010 #1367

The dual selective VEGFR-FGFR kinases inhibitor E-3810 decreases tumor perfusion and inhibits tumor growth: an analyis using dynamic contrast-enhanced magnetic resonance imaging

F. Bichat^a, X. Tizon^a, P. Provent^a, V. Bari^a, R. Cereda^b, G. Camboni^b and E. Cavalletti^b
^aOncodesign, ^bE.O.S.

Download

AACR 2010 #2255

In vivo study of serum cancer biomarkers and pain-induced bone metastasis of human prostate tumor in Nude rats

C. Mignard^a, O. Duchamp^a, F. Bichat^a, S. Gregoire^b,c, Y. Darbaky^b and D. Ardid^c
^aOncodesign, ^bANS Biotech, ^CINSERM U766

Download

AACR 2010 #4169

CReMEC initiative: Characterization of patient-derived colorectal tumor models and correlation with patient profile

S. Julien^a, A. Merino-Trigo^b, L. Lacroix^g,e, M. Pocard^c,e, D. Goéré^g,e, P. Mariani^d,e, S. Landron^h, L. Bigot^g,e, F. Nemati^d,e, L.B. Weiswald^c,e, D. Lantuas^c,e, L. Morgandⁱ, G. Prévost^a, P. Gonin^g,e, V. Dangles-Marie^c,d,e, A. Pierré^h, A. Bruno^h, H. De Thé^e,f, H. Soliman^e,f, M. Nunes^b, L. Calvet^b, P. Vrignaud^b, O. Duchampⁱ and C. Berthetⁱ
^aIpsen, ^bsanofi-aventis, ^cHôpital Lariboisière , ^dInstitut Curie, ^eCancéropole d’Ile de France, ^fInstitut Universitaire d'Hématologie, ^gInstitut Gustave Roussy, ^hInstitut de recherche Servier and ⁱOncodesign

Download

AACR 2010 #5459

Antitumor activity of EP80061, a small-glyco drug in preclinical studies

G. Serin^a, J.F. Mirjolet^a, V. Nancy-Portebois^b, E. Cabannes^b and M. Petitou^b
^aOncodesign, ^bENDOTIS PHARMA

Download

2010 2009 2008 2007 2006 2005-2004 2003-2000

Back

Top

About us / Services & facilities / Our partners & alliances / Media / Careers

Posters

2010

In vivo characterisation of orthotopic prostate tumor and healthy rat prostate metabolism using 1H-MRS at 4.7 T

Oncodesign translational drug discovery process

Development of a fully human immune system in NOD/SCID/ IL2Rgamma (NSG) mice for oncology research purpose

PK and antitumor activity of DEBIO 0507, a new platine derivative, in preclinical tumor models

The dual selective VEGFR-FGFR kinases inhibitor E-3810 decreases tumor perfusion and inhibits tumor growth: an analyis using dynamic contrast-enhanced magnetic resonance imaging

In vivo study of serum cancer biomarkers and pain-induced bone metastasis of human prostate tumor in Nude rats

CReMEC initiative: Characterization of patient-derived colorectal tumor models and correlation with patient profile

Antitumor activity of EP80061, a small-glyco drug in preclinical studies

In vivo characterisation of orthotopic prostate tumor and healthy rat prostate metabolism using ¹H-MRS at 4.7 T